Skip to main content
. Author manuscript; available in PMC: 2011 May 27.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Apr 28;2(5):440–449. doi: 10.1158/1940-6207.CAPR-08-0136

Table 4.

Change in histology measures

Observation Treated Difference* (treated – observed)
Difference 95% CI P
All subjects
n 19 36
 Maximum 0.37 (2.34) 0.03 (1.61) −0.18 (−1.16 to 0.81) 0.72
 Average 0.14 (0.88) −0.17 (1.04) −0.25 (−0.77 to 0.28) 0.35
 Dysplasia index 0.00 (0.29) −0.04 (0.26) −0.02 (−0.16 to 0.12) 0.75
Current smokers
n 9 15
 Maximum −0.56 (1.24) 0.00 (1.81) 0.69 (−0.77 to 2.15) 0.34
 Average 0.01 (0.93) −0.32 (1.34) −0.19 (−1.27 to 0.88) 0.71
 Dysplasia index 0.00 (0.35) −0.11 (0.32) −0.04 (−0.33 to 0.24) 0.76
Former smokers
n 10 21
 Maximum 1.20 (2.82) 0.05 (1.50) −0.92 (−2.31 to 0.47) 0.18
 Average 0.26 (0.87) −0.07 (0.78) −0.31 (−0.84 to 0.23) 0.25
 Dysplasia index 0.01 (0.24) 0.01 (0.20) 0.00 (−0.15 to 0.14) 0.97
*

Adjusted for baseline histology (either maximum, average, or index). All subject analysis is also adjusted for smoking status.